Covered recipient · General Payments record
ZAINAB ZAHRA
General Payments · PY2023–2024
$749.78
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $232.87 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Neurelis, Inc. | $52.46 | 3 |
| Otsuka America Pharmaceutical, Inc. | $37.18 | 2 |
| SK Life Science, Inc. | $36.72 | 2 |
| Genentech USA, Inc. | $23.10 | 1 |
| Lilly USA, LLC | $19.72 | 1 |
| EMD Serono, Inc. | $19.21 | 1 |
| ABBVIE INC. | $17.96 | 1 |
| UCB, Inc. | $13.38 | 1 |
| Acerta Pharma LLC | $13.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.96 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106388132 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.14 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110514158 | CMS |
| EMD Serono, Inc. | $19.21 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120218030 | CMS |
| Genentech USA, Inc. | $23.10 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133136651 | CMS |
| Lilly USA, LLC | $19.72 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135521113 | CMS |
| Neurelis, Inc. | $17.06 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145659207 | CMS |
| Neurelis, Inc. | $18.38 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145659209 | CMS |
| Neurelis, Inc. | $17.02 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145659211 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.18 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119008543 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.00 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119008545 | CMS |
| SK Life Science, Inc. | $18.93 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154134601 | CMS |
| SK Life Science, Inc. | $17.79 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154134718 | CMS |
| UCB, Inc. | $13.38 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143359176 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.